Related Experiment Video

Updated: May 17, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
08:35

Examining BCL-2 Family Function with Large Unilamellar Vesicles

Published on: October 5, 2012

Sirtuin-3 modulates Bak- and Bax-dependent apoptosis

Manish Verma1, Nataly Shulga, John G Pastorino

  • 1Department of Molecular Biology, School of Osteopathic Medicine, University of Medicine and Dentistry of New Jersey, Stratford, NJ 08084, USA.

Journal of Cell Science
|October 31, 2012
PubMed

Insights

Sirtuin-3 depletion promotes cancer cell survival by preventing mitochondrial damage through increased cyclophilin-D activity. Conversely, higher sirtuin-3 levels enhance cell death by reducing this activity.

Area of Science:

  • Mitochondrial Metabolism
  • Cancer Biology
  • Cell Death Pathways

Background:

  • Sirtuin-3 (SIRT3) acts as a tumor suppressor by regulating mitochondrial metabolism.
  • SIRT3 depletion is linked to increased tumor cell survival.
  • The precise mechanisms by which SIRT3 influences cell death remain under investigation.

Purpose of the Study:

  • To elucidate the role of Sirtuin-3 in regulating apoptosis and mitochondrial integrity.
  • To investigate the involvement of cyclophilin-D, hexokinase II, and Bak/Bax in SIRT3-mediated cell death.

Main Methods:

  • Cellular assays to assess apoptosis and mitochondrial injury.
  • Analysis of cyclophilin-D activity.
  • Investigation of hexokinase II binding to mitochondria.
  • Evaluation of Bak/Bax protein activity.

Main Results:

  • Sirtuin-3 depletion stimulates cyclophilin-D activity, promoting hexokinase II binding to mitochondria.
  • This binding prevents Bak/Bax-dependent mitochondrial injury and cell death, conferring an anti-apoptotic phenotype.
  • Increased Sirtuin-3 expression reduces cyclophilin-D activity, detaching hexokinase II and sensitizing cells to apoptosis.

Conclusions:

  • Sirtuin-3 critically regulates cell viability by modulating mitochondrial pathways.
  • The SIRT3-cyclophilin-D-hexokinase II axis is a key determinant of mitochondrial injury and apoptosis.
  • Targeting this pathway may offer therapeutic strategies for cancer treatment.

More Related Videos

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction08:41

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction

Published on: January 12, 2016

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...